Published 19th July 2016

Precision Ocular completes series A round

Portfolio company Precision Ocular, the Oxford-based retinal therapeutics company, has closed a £15.5 million oversubscribed series A funding round. New investor V-Bio Ventures has now joined existing investors Imperial Innovations, Consort Medical, NeoMed, and Hovione Scientia in the Company's successful Series A round.

Read more about Precision Ocular and the funding round

Press contacts